EMERALD ADVISERS LLC
Q4 2025 Form 13-F

LEOLA, PENNSYLVANIA
CIK 0001015083 · CRD 107496 · SEC-registered investment adviser
$3.2B Reported Value Total

EMERALD ADVISERS, LLC reports 43 total accounts under management (AUM). There are 43 discretionary accounts valued at $3,295,095,778, and 0 non-discretionary accounts.

Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
SEC Registered Discretionary Manager
Source: Form ADV filed 2026-03-31
Reported value
$3.2B
Quarter over quarter
+6.7%
Holdings
246
Top-10 concentration
19.2%

Filing Structure

Reports holdings for

  • PGIM INVESTMENTS LLC · File #028-19510 · Q1 2024 – Q4 2024 · declared by one filing
  • AST Investment Services,inc (not a 13F filer in our records) · File #028-19512 · Q1 2019 – Q3 2020 · declared by one filing

Key People

Form ADV owners & control persons
John Thomas Hailer
MEMBER/MANAGER
James Andrew Meehan
CHIEF COMPLIANCE OFFICER
Kenneth George Mertz
CHIEF EXECUTIVE OFFICER, PRESIDENT AND DIRECTOR

Filing Navigation

13F Metrics

Loading 13F Metrics

Q4 2025 13F record

Q4 2025 13F filing summary

Q4 2025 Form 13F portfolio summary
Period of report December 31, 2025
Filed February 09, 2026
Form 13F-HR
Reported value $3.2B
Positions 246
Change in reported value +4.1%
New positions 13
Exited positions 24
Position turnover 13.7%
Top-10 concentration 19.2%

13F filings by quarter

Form 13F filings by quarter
Quarter Positions Value
Q3 2026 13F
Filed Nov 9, 2026
224 $3.6B
Q2 2026 13F
Filed Aug 5, 2026
237 $4.2B
Q1 2026 13F
Filed May 4, 2026
248 $3.2B
Q4 2025 13F
Filed Feb 9, 2026
246 $3.2B
Q3 2025 13F
Filed Oct 30, 2025
256 $3.1B
Q2 2025 13F
Filed Aug 4, 2025
248 $2.7B
Q1 2025 13F
Filed May 1, 2025
243 $2.2B
Q4 2024 13F
Filed Feb 11, 2025
254 $2.6B
Q3 2024 13F
Filed Oct 29, 2024
248 $2.6B
Q2 2024 13F
Filed Aug 6, 2024
247 $2.4B
Q1 2024 13F
Filed May 8, 2024
243 $2.5B
Q4 2023 13F
Filed Feb 5, 2024
242 $2.3B
Q3 2023 13F
Filed Oct 26, 2023
232 $2.1B
Q2 2023 13F
Filed Jul 25, 2023
211 $2.3B
Q1 2023 13F
Filed May 4, 2023
210 $2.1B
Q4 2022 13F
Filed Feb 3, 2023
245 $2.1B
Q3 2022 13F
Filed Oct 25, 2022
243 $1.9B
Q2 2022 13F
Filed Jul 29, 2022
245 $1.9B
Q1 2022 13F
Filed Apr 29, 2022
257 $2.6B
Q4 2021 13F
Filed Feb 2, 2022
276 $2.7B

34 earlier quarters on file — choose one from the quarter menu above.

Top 20 holdings · Q4 2025

Largest Q4 2025 13F positions by reported value
# Holding Reported value % of portfolio
1 GH GUARDANT HEALTH INC $88.0M 2.71%
2 CRDO CREDO TECHNOLOGY GROUP HOLDINGS $71.4M 2.2%
3 KTOS KRATOS DEFENSE AND SECURITY $66.4M 2.05%
4 TTMI TTM TECHNOLOGIES INC $63.1M 1.95%
5 TVTX TRAVERE THERAPEUTICS INC $60.9M 1.88%
6 RMBS RAMBUS INC $57.6M 1.78%
7 COGT COGENT BIOSCIENCES INC $56.2M 1.73%
8 LITE LUMENTUM HOLDINGS INC $54.5M 1.68%
9 MOD MODINE MANUFACTURING CO $52.1M 1.6%
10 AVAV AEROVIRONMENT INC $51.2M 1.58%
11 FN FABRINET $49.8M 1.53%
12 BE BLOOM ENERGY CO $48.6M 1.5%
13 VSEC VSE CORPORATION $48.3M 1.49%
14 AX AXOS FINANCIAL INC $44.9M 1.38%
15 LIVN LIVANOVA PLC $43.1M 1.33%
16 TMDX TRANSMEDICS GROUP INC $42.7M 1.32%
17 MC MOELIS & CO $42.3M 1.3%
18 WVE WAVE LIFE SCIENCES LTD $41.7M 1.29%
19 BBIO BRIDGEBIO PHARMA INC $41.0M 1.26%
20 PLMR PALOMAR HOLDINGS INC $40.7M 1.25%

Values as reported on the Q4 2025 Form 13F. Every position is in the holdings table below.

Filing Details

Loading Activities
Loading Sector Allocation
Crunching numbers

Performance

Loading Performance

Potential New Buys

Finding Potential New Buys

Holdings

Building table
Loading SEC filing data
Loading Form 4 Filings

Beneficial Ownership (Schedule 13D/13G)

Loading 13D/G filings